We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...

Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s better-regulated drugs on the market.

Add Yahoo as a preferred source to see more of our stories on Google. Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

People with diabetes who also suffer from heart failure were at less risk of serious health issues, including hospitalisation ...

FRESNO, Calif. (KFSN) -- With weight-loss pills being released in the U.S. for the first time, the intensely competitive weight-loss market is becoming more affordable. Local experts are now weighing ...

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...

GLP-1 receptor agonists, of which semaglutide (a.k.a. Ozempic) is the most well known example, has revolutionized obesity ...